New form of vaccine therapy — for low-risk prostate cancer

According to a media report on the MarketWatch web site, a company called OncBioMune is to initiate Phase II clinical trials of a new type of prostate cancer vaccine (ProscaVax). … READ MORE …

Statin therapy lowers mortality rates among Danish prostate cancer patients

According to a media release and a presentation given at the European Association of Urology (EAU) in Europe this week, statin therapy has a small but significant impact on overall and prostate cancer-specific mortality rates. … READ MORE …

Screening and the incidence of newly diagnosed, metastatic prostate cancer over time

Another article in this week’s issue of the New England Medical Journal is going to re-fuel the fire among those who advocate for widespread, frequent screening of men for risk of prostate cancer. … READ MORE …

Master gene reprogramming and the development of prostate cancer

According to an hypothesis just published by a group of researchers at the Dana-Farber Cancer Institute in Boston, they have identified “a new epigenetic program occurring as you transition from normal to tumor cells” in the development of prostate cancer. … READ MORE …

Primary melanoma of the prostate

Primary melanoma of the prostate is so rare that only five cases of this disorder have ever been reported in the medical literature — and your sitemaster had never even heard of this form of prostate cancer prior to seeing the care report referred to below. … READ MORE …

Introducing PCPC3

The following statement was issued this morning by a new, patient-centric group of prostate cancer education, advocacy, and support organizations here in the USA. As indicated below, Prostate Cancer International — the parent organization behind The “New” Prostate Cancer InfoLink — is a founder member of the new group. … READ MORE …

Prostate biopsies and effects on erectile function post-biopsy

There have long been suggestions that having a prostate biopsy could be associated with at least a temporary decline in erectile function. A new study in BJU International has now shed more light on this matter. … READ MORE …

New recommendations from the AUA through “Choosing Wisely” initiative

Yesterday the American Urology Association (AUA) issued a second set of five recommendations to its members through the Choosing Wisely initiative (which is coordinated by the ABIM Foundation). Two of these recommendations were specific to risk for prostate cancer and its management. … READ MORE …

Familial risk for prostate cancer ups risk for breast cancer too

Just a few days ago, a paper in Cancer reported that familial risk for breast cancer in women appeared to be affected not only by a familial history of breast cancer but also by a familial history of prostate cancer among close family members. … READ MORE …

More data that will cause controversy in the screening debate

Data from a very large, 25-year-long, randomized, controlled trial of screening for cancer has cast further doubt on the value of mass, annual, population-based screening as a way to reduce cancer deaths. … READ MORE …

New AUA guidance on prostate biopsies and processing of biopsy specimens

For those who are interested in such details, the American Urology Association (AUA) has just issued new guidance on the conduct of prostate biopsies and the processing of biopsy specimens. The full text of this document is available on line. A complementary review article is also published in the Journal of Urology.

LUGPA reacts to suggestions of excessive prostate biopsies in Health Affairs

Not surprisingly, a major urology organization (the Large Urology Group Practice Association or LUGPA) has aggressively disputed the findings recently published by Mitchell in Health Affairs regarding the numbers of prostate biopsies conducted by urology groups with in-house pathology laboratories (see earlier commentary). … READ MORE …

Is the word “cancer” out of date? What’s in a name?

An article in today’s New York Times (“‘Cancer’ or ‘weird cells’: which sounds deadlier?“) focuses on the question of whether many conditions currently referred to as “cancer” really are … and whether by calling them “cancer” we prejudice doctors and patients into taking overly aggressive action. … READ MORE …

Prostate cancer news reports: Saturday, April 3, 2010

Today’s news reports deal with such items as:

  • The effects of antiretroviral drugs for HIV/AIDS on the XMRV virus
  • Diet, milk, and prostate cancer etiology
  • Can saturation biopsies really identify low-risk cancers?
  • Prostate weight and prostate cancer recurrence … READ MORE …

Tuesday’s news and reports: December 16, 2008

There are a number of interesting (if somewhat technical) reports today dealing with the following issues:

  • The size and metabolism of the “normal” prostate and their relationship to age
  • Defining who is potentially appropriate for focal therapy
  • Saw palmetto berry extract as an anti-tumor agent?
  • Is chlormanidone a helpful non-steroidal antiandrogen? … READ MORE …